Milestone Pharmaceuticals, Inc.
MIST · NASDAQ · USD
$0.7585
+0.0464 6.52%todayNot financial advice.
- Open
- 0.7200
- Day range
- 0.7075 - 0.7700
- 52-week range
- 0.7075 - 3.06
- Volume
- 978.08K
- Market cap
- 94.43M
- P/E ratio
- —
- EPS
- -0.69
- Dividend yield
- 0.00%
- Beta
- 3.68
Performance
W
−7.04%
1M
−32.88%
3M
−41.65%
6M
−63.00%
YTD
−62.82%
Y
−62.27%
5Y
−86.21%
All
−95.14%
In the news
Oct 9
Milestone Pharmaceuticals Enrolls First European Patient in Phase 3 AFib Trial
Milestone Pharmaceuticals enrolled its first European patient in a Phase 3 trial of its etripamil nasal spray for rapid heart rate conditions.
Company news
Oct 9
Milestone Pharmaceuticals Advances Heart Drug Trial with First European Patient
Milestone Pharmaceuticals has enrolled its first European patient in a Phase 3 study for an AFib-RVR nasal spray, which could reduce ER visits.
Company news
Embed on your site
Embed docsAdd a live price card or a chart to any page. Free, no sign-up; cards refresh every minute and link back here.
<iframe src="https://stocks.freetheai.org/embed/NASDAQ-MIST" width="340" height="170" style="border:0;max-width:100%" loading="lazy" title="Milestone Pharmaceuticals, Inc. (MIST) - FreeTheAI Stocks"></iframe>
<p style="font-size:12px"><a href="https://stocks.freetheai.org/symbols/NASDAQ-MIST">MIST stock price</a> by FreeTheAI Stocks</p>